Genetic detection of cancer cells is a necessary way to guide some targeted drugs to treat cancer. Clinically, patients' tumor tissues or peripheral blood, pleural effusion, peritoneal effusion, cerebrospinal fluid and other samples can usually be used for genetic testing, and the items required for genetic testing of different cancers are obviously different. At present, gene testing is emphasized in the treatment of breast cancer, lung cancer and colorectal cancer, especially in advanced cancer. At this time, if gene mutation occurs, corresponding targeted drugs can be used for some gene mutations, such as EGFR gene mutation of lung cancer, HER2 gene mutation of breast cancer, KRAS gene mutation of colorectal cancer and so on. These conditions can be used in conjunction with the corresponding targeted drugs, because there is a gene mutation, the effect of using targeted drugs is better than that of using chemotherapy, or more targeted drugs can be used on the basis of chemotherapy.
For more information about genetic testing, please consult Hyplos. Hyplos's medical laboratory has passed CAP (American Association of Pathologists) /EMQN (European Union for the Quality of Molecular Gene Diagnosis)/Clinical Center of China Ministry of Health and other authoritative certifications, covering the whole process of tumor management, genetic disease screening, major infectious diseases (including COVID-19 nucleic acid) and other fields. It has provided genetic testing technical services and overall solutions for more than 500 3A hospitals, hundreds of scientific research institutes, physical examination institutions, insurance companies, Internet platforms and local governments. ● Is it necessary to do genetic testing if you are not sick? A n experienced person has something to say. ......